Nap-Protected Oligosaccharide Synthesis for Pneumococcal Vaccines
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing oligosaccharides derived from the repeating unit of Streptococcus pneumoniae type 3 are elaborate, with low yields and many tedious reaction steps, making them impractical for producing tetrasaccharides, hexasaccharides, and octasaccharides suitable for conjugation to carrier proteins or glycosphingolipids.
Innovation Solution
A synthetic method using the 2-naphthylmethyl protecting group (Nap) facilitates the formation of crystalline intermediates, allowing for higher yields and easier purification, and enables the conjugation of tetrasaccharides, hexasaccharides, and octasaccharides to carrier proteins or glycosphingolipids through selective removal and oxidation steps.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional synthetic methods are used to prepare ST3 oligosaccharides, then the oligosaccharides can be produced, but the synthesis is elaborate with low yields and many tedious reaction steps
Solution Approach 1:
The patent changes the chemical parameters by introducing the 2-naphthylmethyl (Nap) protecting group system, which enables crystalline intermediates to form during synthesis. This parameter change transforms the synthesis from a series of low-yield liquid-phase reactions to a high-yield process with solid intermediates that can be purified by simple filtration and washing, dramatically improving productivity and reducing procedural complexity
Solution Approach 2:
The patent exploits phase transitions by designing the synthesis to produce crystalline intermediates at key stages. The Nap-protected oligosaccharide intermediates precipitate as solids from reaction mixtures, allowing separation by filtration rather than requiring complex chromatographic purification. This phase transition from liquid to solid state simplifies the synthesis procedure and increases yields
2Quantity of substance
If hydrolysis of capsular polysaccharide is used, then oligosaccharides can be obtained, but separation of different fragments is difficult and results in mixtures
Solution Approach 1:
The patent applies segmentation by synthesizing the oligosaccharide chain in controlled segments using stepwise glycosylation. Each glycosylation step adds a specific glucose unit with defined stereochemistry, building the oligosaccharide segment by segment rather than relying on random hydrolytic cleavage. This ensures precise structural definition while producing the desired oligosaccharide quantities
Solution Approach 2:
The patent uses preliminary action by pre-assembling small oligosaccharide units with protected hydroxyl groups before final assembly. The Nap protecting groups are installed early in the synthesis, and these protected intermediates are purified and characterized before further elongation. This preliminary structuring ensures that the final product has the precise repeating unit structure [→3)-β-D-GlcpA-(1→4)-β-D-Glcp-(1→] without contamination from side products
3Manufacturing precision
If sequential coupling of glucose molecules is used, then oligosaccharides can be synthesized, but the synthesis becomes elaborate for longer oligosaccharides with only one glucose unit introduced per step
Solution Approach 1:
The patent merges multiple glycosylation steps into更高效 sequences by using the Nap protecting group strategy. The Nap group at the 2-position of glucuronic acid allows for accelerated glycosylation reactions and enables the coupling of larger oligosaccharide blocks. This merging of steps reduces the total number of operations required to synthesize long oligosaccharides like tetrasaccharides, hexasaccharides, and octasaccharides
Solution Approach 2:
The Nap-protected glucuronic acid derivative acts as an intermediary that facilitates faster glycosylation. The Nap group enhances the reactivity of the glycosyl donor and stabilizes the reaction intermediate, allowing for more efficient coupling reactions. This intermediary enables the synthesis of longer oligosaccharides in fewer steps compared to conventional methods
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides a more efficient and scalable synthesis of ST3 oligosaccharides with improved yields and simplified purification, enabling the production of high-titer antibodies with opsonophagocytosis and bactericidal activity for pneumococcal vaccines.
Implementation Method 1
A synthetic method using the 2-naphthylmethyl protecting group (Nap) facilitates the formation of crystalline intermediates, allowing for higher yields and easier purification
Implementation Method 2
enables the conjugation of tetrasaccharides, hexasaccharides, and octasaccharides to carrier proteins or glycosphingolipids through selective removal and oxidation steps
Data Source
AI summary
The present invention relates to the preparation of a synthetic tetrasaccharide, hexasaccharide and octasaccharide representing part of the repeating unit of the Streptococcus pneumoniae type 3 capsular polysaccharide as well as conjugates thereof. Said conjugates are particularly useful for prevention and/or treatment of diseases associated with Streptococcus pneumoniae, and more specifically of diseases associated with Streptococcus pneumoniae type 3. The disclosed synthetic method has the huge advantages over the state of the artsynthetic methods that intermediate products are crystalline, coupling reaction yields are higher, less reaction steps are required and purification of intermediate products is easier.